BSE Live
Jan 20, 16:01Prev. Close
4090.80
Open Price
4124.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 20, 15:59Prev. Close
4086.60
Open Price
4105.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
3976.80 (117)
| Key Financial Ratios of Torrent Pharmaceuticals (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 36.83 | 45.05 | 64.58 | 36.79 | 34.38 | |
| Diluted EPS (Rs.) | 36.83 | 45.05 | 64.58 | 36.79 | 34.38 | |
| Cash EPS (Rs.) | 47.47 | 49.74 | 73.02 | 44.33 | 41.24 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 159.87 | 135.30 | 195.12 | 154.16 | 129.17 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 159.87 | 135.30 | 195.12 | 154.16 | 129.17 | |
| Dividend / Share(Rs.) | 11.25 | 10.00 | 23.00 | 8.50 | 8.00 | |
| Revenue from Operations/Share (Rs.) | 205.36 | 198.82 | 326.90 | 245.34 | 207.02 | |
| PBDIT/Share (Rs.) | 67.89 | 64.77 | 95.82 | 63.29 | 53.78 | |
| PBIT/Share (Rs.) | 57.24 | 60.08 | 87.37 | 55.74 | 46.91 | |
| PBT/Share (Rs.) | 47.04 | 56.62 | 78.62 | 43.81 | 42.29 | |
| Net Profit/Share (Rs.) | 36.82 | 45.04 | 64.57 | 36.78 | 34.37 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 33.06 | 32.57 | 29.31 | 25.79 | 25.97 | |
| PBIT Margin (%) | 27.87 | 30.21 | 26.72 | 22.72 | 22.65 | |
| PBT Margin (%) | 22.90 | 28.48 | 24.05 | 17.85 | 20.43 | |
| Net Profit Margin (%) | 17.93 | 22.65 | 19.75 | 14.99 | 16.60 | |
| Return on Networth / Equity (%) | 23.03 | 33.29 | 33.09 | 23.85 | 26.61 | |
| Return on Capital Employed (%) | 12.02 | 24.08 | 24.35 | 17.78 | 19.80 | |
| Return on Assets (%) | 9.57 | 17.59 | 16.28 | 12.07 | 13.09 | |
| Total Debt/Equity (X) | 0.84 | 0.42 | 0.35 | 0.35 | 0.36 | |
| Asset Turnover Ratio (%) | 53.39 | 77.66 | 82.44 | 80.51 | 78.84 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 2.06 | 2.29 | 1.86 | 1.72 | 1.60 | |
| Quick Ratio (X) | 1.47 | 1.69 | 1.23 | 1.24 | 1.14 | |
| Inventory Turnover Ratio (X) | 4.45 | 4.84 | 3.97 | 5.28 | 5.11 | |
| Dividend Payout Ratio (NP) (%) | 30.54 | 22.20 | 35.61 | 23.10 | 23.27 | |
| Dividend Payout Ratio (CP) (%) | 23.69 | 20.10 | 31.49 | 19.17 | 19.39 | |
| Earnings Retention Ratio (%) | 69.46 | 77.80 | 64.39 | 76.90 | 76.73 | |
| Cash Earnings Retention Ratio (%) | 76.31 | 79.90 | 68.51 | 80.83 | 80.61 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 21,861.77 | 9,598.56 | 6,184.61 | 5,413.03 | 5,021.19 | |
| EV/Net Operating Revenue (X) | 6.29 | 2.85 | 2.24 | 2.61 | 2.87 | |
| EV/EBITDA (X) | 19.03 | 8.76 | 7.63 | 10.11 | 11.03 | |
| MarketCap/Net Operating Revenue (X) | 5.65 | 2.63 | 2.13 | 2.56 | 2.79 | |
| Retention Ratios (%) | 69.45 | 77.79 | 64.38 | 76.89 | 76.72 | |
| Price/BV (X) | 7.26 | 3.87 | 3.56 | 4.08 | 4.48 | |
| Price/Net Operating Revenue | 5.65 | 2.63 | 2.13 | 2.56 | 2.79 | |
| Earnings Yield | 0.03 | 0.09 | 0.09 | 0.06 | 0.06 |
09.01.2026
05.12.2025
14.11.2025
Torrent Pharma Consolidated September 2025 Net Sales at Rs 3,302.00 crore, up 14.3% Y-o-Y
12.11.2025
Torrent Pharma Standalone September 2025 Net Sales at Rs 2,762.00 crore, up 13.48% Y-o-Y
14.11.2025
Torrent Pharma Consolidated September 2025 Net Sales at Rs 3,302.00 crore, up 14.3% Y-o-Y
12.11.2025
Torrent Pharma Standalone September 2025 Net Sales at Rs 2,762.00 crore, up 13.48% Y-o-Y
29.07.2025
Torrent Pharma Consolidated June 2025 Net Sales at Rs 3,178.00 crore, up 11.16% Y-o-Y
29.07.2025
Torrent Pharma Standalone June 2025 Net Sales at Rs 2,616.00 crore, up 7.3% Y-o-Y
12.07.2023
Torrent Pharma Q1 PAT may dip 9.7% YoY to Rs 319.7 cr: Nirmal Bang
17.01.2023
Torrent Pharma Q3 PAT seen up 28.9% YoY to Rs 3,211 cr: Nirmal Bang
13.07.2022
Torrent Pharma Q1 PAT seen up 2.8% YoY to Rs 339.1 cr: ICICI Direct
08.07.2022
Torrent Pharmaceuticals Q1 PAT seen up 1.4% YoY to Rs 334.5 cr: Prabhudas Lilladher
24.07.2019
Torrent Pharma shares jump 6% as brokerages remain bullish after Q1 show
25.08.2018
Pharma Q1 review: Brokerages say performance a mixed bag, but are upbeat on domestic biz
22.01.2014
14.01.2012